Treatment and Prognostic Significance of Positive Interval Sentinel Nodes in Patients with Primary Cutaneous Melanoma

被引:22
|
作者
Verwer, Nick [1 ,2 ]
Scolyer, Richard A. [1 ,3 ,4 ]
Uren, Roger F. [1 ,5 ,6 ]
Winstanley, Julie [1 ]
Brown, Philip T. [1 ]
de Wilt, Johannes H. W. [7 ]
Thompson, John F. [1 ,8 ]
机构
[1] Melanoma Inst Australia, Sydney, NSW, Australia
[2] ErasmusMC, Rotterdam, Netherlands
[3] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia
[4] Univ Sydney, Discipline Pathol, Sydney Med Sch, Sydney, NSW 2006, Australia
[5] RPAH Med Ctr, Newtown, Tas, Australia
[6] Univ Sydney, Discipline Med, Sydney Med Sch, Sydney, NSW 2006, Australia
[7] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6525 ED Nijmegen, Netherlands
[8] Univ Sydney, Sydney Med Sch, Discipline Surg, Sydney, NSW 2006, Australia
关键词
HUMAN SERUM-ALBUMIN; LYMPH-NODES; LYMPHOSCINTIGRAPHY; IDENTIFICATION; METASTASIS; DRAINAGE; CANCER; SITES;
D O I
10.1245/s10434-011-1988-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Interval sentinel nodes (SNs) are lymph nodes receiving direct lymphatic drainage from a primary site and lying between the tumor and a recognized node field. It is not clear what further nodal surgery should be performed when interval nodes are found to contain micrometastatic disease. In this study, the incidence, location, and treatment of interval SNs in melanoma patients were analyzed to develop recommendations regarding the treatment of patients with interval SNs. Methods. A retrospective review was undertaken of all patients with primary cutaneous melanoma who underwent lymphoscintigraphy at a single institution between 1992 and 2007. Data concerning the primary melanoma, location of SNs, treatment and survival were analyzed. Results. Of 4895 patients who had a lymphoscintigram during the study period, 442 (9.0%) had an interval SN identified on lymphoscintigraphy. Interval SNs occurred significantly more often in patients with melanomas on the posterior trunk than in those with melanomas at other sites (P < 0.001). A total of 197 patients (44.6%) with an identified interval SN underwent excision biopsy of the node. Of the 16 patients found to have metastatic melanoma in their interval SN, four also had negative SNs in a recognized lymph node field, and no other positive nodes were found on completion lymphadenectomy. Conclusions. Interval SNs are present in approximately 1 in 10 melanoma patients but are about half as likely to contain metastases as SNs in recognized node fields. If a positive interval SN is found, completion lymphadenectomy of the recognized lymph node field is only recommended if a SN in this field is also positive.
引用
收藏
页码:3292 / 3299
页数:8
相关论文
共 50 条
  • [31] Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma
    Warso, MA
    Maniotis, AJ
    Chen, X
    Majumdar, D
    Patel, MK
    Shilkaitis, A
    Das Gupta, TK
    Folberg, R
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 473 - 477
  • [32] Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients
    Takeuchi, H
    Morton, DL
    Kuo, C
    Turner, RR
    Elashoff, D
    Elashoff, R
    Taback, B
    Fujimoto, A
    Hoon, DSB
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (13) : 2671 - 2680
  • [33] Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma
    Karakousis, Giorgos C.
    Pandit-Taskar, Neeta
    Hsu, Meier
    Panageas, Katherine
    Atherton, Sonny
    Ariyan, Charlotte
    Brady, Mary S.
    MELANOMA RESEARCH, 2013, 23 (01) : 40 - 46
  • [34] Prognostic significance of extent of ulceration in primary cutaneous melanoma
    Sarpa, Hege Grande
    Reinke, Kara
    Shaikh, Ladan
    Leong, Stanley P. L.
    Miller, James R., III
    Sagebiel, Richard W.
    Kashani-Sabet, Mohammed
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (11) : 1396 - 1400
  • [35] Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma
    Paver, Elizabeth C.
    Ahmed, Tasnia
    Burke, Hazel
    Saw, Robyn P. M.
    Stretch, Jonathan R.
    Spillane, Andrew J.
    Shannon, Kerwin F.
    Vergara, Ismael A.
    Elder, David E.
    Lo, Serigne N.
    Thompson, John F.
    Scolyer, Richard A.
    JAMA DERMATOLOGY, 2023, 159 (12) : 1359 - 1367
  • [36] Evaluation of nodal cellular morphology and pigmentation as prognostic factors in melanoma patients with positive sentinel nodes
    Bertolli, E.
    Macedo, M. P.
    Molina, A. S.
    Damascena, A. S.
    Pinto, C. A. L.
    Duprat Neto, J. P.
    MELANOMA RESEARCH, 2016, 26 : E22 - E23
  • [37] Isolated HMB45 or MelanA positive cells are without prognostic significance in melanoma sentinel lymph nodes
    Satzger, I.
    Völker, B.
    Kapp, A.
    Gutzmer, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : S30 - S30
  • [38] Correlation between Metastatic Tumor Burden in Sentinel and Non-Sentinel Lymph Nodes and Prognostic Significance of Tumor Burden in Sentinel Nodes in 336 Patients with Cutaneous Melanoma: A Single-Institution Retrospective Study
    Aung, Phyu
    Namikawa, Kenjiro
    Milton, Denai
    Nagarajan, Priyadharsini
    Tetzlaff, Michael
    Curry, Jonathan
    Ivan, Doina
    Torres-Cabala, Carlos
    Prieto, Victor
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 453 - 454
  • [39] Clinical Significance of BRAFV600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma
    Siroy, Alan E.
    Torres-Cabala, Carlos A.
    Tetzlaff, Michael T.
    Nagarajan, Priyadharsini
    Milton, Denai R.
    Curry, Jonathan L.
    Prieto, Victor G.
    Aung, Phyu P.
    MODERN PATHOLOGY, 2016, 29 : 136A - 136A
  • [40] Correlation between Metastatic Tumor Burden in Sentinel and Non-Sentinel Lymph Nodes and Prognostic Significance of Tumor Burden in Sentinel Nodes in 336 Patients with Cutaneous Melanoma: A Single-Institution Retrospective Study
    Aung, Phyu
    Namikawa, Kenjiro
    Milton, Denai
    Nagarajan, Priyadharsini
    Tetzlaff, Michael
    Curry, Jonathan
    Ivan, Doina
    Torres-Cabala, Carlos
    Prieto, Victor
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 453 - 454